{
  "meta": {
    "title": "21_Connective_Tissue_Disorders",
    "url": "https://brainandscalpel.vercel.app/21-connective-tissue-disorders-c0ed75d1.html",
    "scrapedAt": "2025-11-30T12:27:35.427Z"
  },
  "questions": [
    {
      "text": "Which of the following is the most common site involved in discoid lupus erythematosus?",
      "choices": [
        {
          "id": 1,
          "text": "Fingers"
        },
        {
          "id": 2,
          "text": "Scalp and face"
        },
        {
          "id": 3,
          "text": "Trunk"
        },
        {
          "id": 4,
          "text": "Side of neck"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Discoid lupus erythematosus</strong> is a benign inflammatory disorder of the skin, <strong>most frequently</strong> involving the<strong> face</strong> and<strong> scalp.&nbsp;</strong></p>\n<p>It is characterized by well‐defined red, scaly patches of variable size, which heal with atrophy, scarring, and pigmentary changes.&nbsp;The <strong>circumscribed</strong> or<strong> discoid</strong> form is the most frequent type of disease and occurs particularly on the <strong>cheeks</strong>, bridge of the <strong>nose</strong>, <strong>ears, side of the neck, and scalp</strong>.</p>\n<p>The image below shows a localized discoid lupus erythematosus of the scalp with follicular plugging.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5f0cd07feddb43fb97445b845af3ab79x1280x2022.0028208744711.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2768",
      "difficulty": "easy"
    },
    {
      "text": "A dermoscopy examination in a patient who presented with alopecia revealed the following finding. Identify the condition.",
      "choices": [
        {
          "id": 1,
          "text": "Alopecia aerata"
        },
        {
          "id": 2,
          "text": "Discoid lupus erythematosus"
        },
        {
          "id": 3,
          "text": "Dermatomyositis"
        },
        {
          "id": 4,
          "text": "Lupus vulgaris"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image shows <strong>hyperkeratosis</strong> and <strong>plugging</strong> of the <strong>follicular ostia</strong> with keratotic material, otherwise known as the<strong>&nbsp;carpet tack sign</strong> or<strong> tin- tack sign,</strong> or<strong> cat's tongue sign,</strong>&nbsp;seen in <strong>discoid lupus erythematosus</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e98cd53c61274ff398ad75d78b0f64c1x1200x1709.JPEG\" alt=\"Explanation Image\"><p>In cutaneous lupus erythematosus or discoid lupus erythematosus, the skin lesions present as well-defined&nbsp;<strong>erythematous patches</strong> with <strong>adherent</strong> <strong>scaling </strong>and<strong> peripheral hyperpigmentation. </strong>When the scale is removed its undersurface shows horny plugs that have occupied dilated pilosebaceous canals. This is called the &lsquo;tin‐tack&rsquo; sign.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6cb6a2af60c04b4099e82f7e55aabde7x401x269.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/be6e7f2a855942c09feaaa52f0360572.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5276",
      "difficulty": "easy"
    },
    {
      "text": "A 40-year-old man presented to the dermatologist with alopecia and the following disfiguring lesions. His history was suggestive of Raynaud's phenomenon. On examination, wide follicular pits were noted in the concha. ANA titres were normal. Identify the false statement regarding his condition.",
      "choices": [
        {
          "id": 1,
          "text": "Topical steroids is the first line treatment for localised lesions"
        },
        {
          "id": 2,
          "text": "Histology shows lymphocytic interface dermatitis with basal layer degeneration"
        },
        {
          "id": 3,
          "text": "Antimalarials can be used for treatment"
        },
        {
          "id": 4,
          "text": "Non-scarring alopecia is typically seen in this condition"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The clinical scenario along with the image showing discoid lesions on the face with central scarring and active erythematous margins with adherent scales are suggestive of <strong>discoid lupus erythematosus.</strong> <strong>Scarring</strong> type of<strong> alopecia</strong> is seen in discoid lupus erythematosus (DLE).</p>\n<p>Histology of DLE shows <strong>lymphocytic interface dermatitis</strong> with<strong> basal layer degeneration</strong>, follicular plugging, dermal mucinosis, and epidermal atrophy.</p>\n<p>The<strong> first-line treatment</strong> for localized lesions is <strong>topical corticosteroids.&nbsp;</strong></p>\n<p>Hydroxychloroquine and chloroquine are <strong>oral antimalarial drugs</strong> that can be used along with oral steroids and have a good response rate.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/69016698dfe940b0abfafba9682165f5x1280x1009.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/50731ebf2d6747388344719356b3a626.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2770",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common cutaneous presentation of subacute cutaneous lupus erythematosus?",
      "choices": [
        {
          "id": 1,
          "text": "Scarring papulosquamous eruption"
        },
        {
          "id": 2,
          "text": "Non-scarring papulosquamous eruption"
        },
        {
          "id": 3,
          "text": "Annular polycyclic lesions"
        },
        {
          "id": 4,
          "text": "Discoid plaque with adherent scale"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Subacute cutaneous lupus erythematosus</strong>&nbsp;presents most commonly as a <strong>non‐scarring papulosquamous eruption.</strong>&nbsp;It can also present as annular polycyclic lesions.</p>\n<p>Sites of lesions:</p>\n<ul>\n<li>Above the waist</li>\n<li>Around the neck</li>\n<li>On the trunk</li>\n<li>Outer aspects of the arms</li>\n</ul>\n<p>The image below shows <strong>psoriasiform lesions</strong> of subacute cutaneous lupus erythematosus.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/992b257b123d4dd6865ddd5367ad1278x512x363.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2773",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following is the most common cutaneous manifestation of systemic lupus erythematosus?",
      "choices": [
        {
          "id": 1,
          "text": "Chronic urticaria"
        },
        {
          "id": 2,
          "text": "Malar rash"
        },
        {
          "id": 3,
          "text": "Raynaud's Phenomenon"
        },
        {
          "id": 4,
          "text": "Photosensitivity"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>most common cutaneous</strong> manifestation of <strong>systemic lupus erythematosus</strong> is <strong>photosensitivity</strong>.</p>\n<p>In decreasing order, the cutaneous manifestations in SLE are:</p>\n<ol>\n<li>Photosensitivity</li>\n<li>Raynaud's phenomenon </li>\n<li>Malar rash</li>\n<li>Chronic urticaria &gt;36 hrs</li>\n<li>Non-scarring alopecia </li>\n<li>Mouth ulceration</li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5398",
      "difficulty": "medium"
    },
    {
      "text": "A young woman presented to the OPD with the following rash. She also complained of myalgia, arthralgia, and hair loss. Her history was significant for sun-induced skin problems. Lupus band test was found to be positive only in the involved skin. Which of the following antibodies is closely associated with this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-Ro (SS-A)"
        },
        {
          "id": 2,
          "text": "Anti-Ribosomal P"
        },
        {
          "id": 3,
          "text": "Anti-La (SS-B)"
        },
        {
          "id": 4,
          "text": "Anti-RNP"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image shows a psoriasiform papulosquamous lesion on the sun-exposed area(back). Along with the history and the positive lupus band test only in the involved skin, a diagnosis of <strong>subacute cutaneous lupus erythematosus&nbsp;</strong>can be made.&nbsp;Antibodies to the <strong>Ro/SS‐A</strong> antigen are almost universally present in this subgroup.&nbsp;</p>\n<p>Subacute cutaneous lupus erythematosus is a specific &lsquo;subset&rsquo; of lupus in which patients exhibit mainly<strong> cutaneous disease</strong> and usually have a <strong>good prognosis</strong>.</p>\n<p>The<strong> lupus band test</strong> (LBT) is a <strong>direct immunofluorescence</strong>&nbsp;technique for demonstrating a <strong>band</strong> of localized <strong>immunoglobulins</strong> at the <strong>dermal-epidermal junction</strong> in the skin of patients with lupus erythematosus (LE).</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b33a46901852420bba18e970fda355e8.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2772",
      "difficulty": "medium"
    },
    {
      "text": "A 20-year-old woman presented to the hospital with complaints of jamais vu and new-onset seizures. CT brain was normal. Her laboratory values are given below. Which of the following is not a dermatological manifestation of this disorder?<div class='question-desc-html'><ul>\n<li>Hemoglobin- 8.0g/dl&nbsp;</li>\n<li>Platelet count- 116,000/&mu;L</li>\n<li>ANA titres- &gt;1:80</li>\n<li>Anti-dsDNA- positive</li>\n</ul></div>",
      "choices": [
        {
          "id": 1,
          "text": "Discoid lesions"
        },
        {
          "id": 2,
          "text": "Painless ulcers on hard palate"
        },
        {
          "id": 3,
          "text": "Photosensitivity"
        },
        {
          "id": 4,
          "text": "Salmon rash"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical details are suggestive of <strong>systemic lupus erythematosus</strong> (SLE).<strong>&nbsp;Salmon rash</strong>&nbsp;is seen in <strong>adult-onset</strong> of <strong>Still's disease.</strong> It is a rare systemic inflammatory disease&nbsp;characterized by the classic triad of:</p>\n<ol>\n<li>Persistent high spiking fever</li>\n<li>Joint pain</li>\n<li>Salmon rash</li>\n</ol>\n<p><strong>SLE&nbsp;</strong>is more common in <strong>females </strong>(7:1 to 15:1).<strong>&nbsp;</strong>It is associated with classical erythematous rash, typically sparing the nasolabial folds called<strong>&nbsp;malar/butterfly rash.&nbsp;<br /></strong></p>\n<p><strong>Discoid rashes</strong> resembling discoid lupus erythematosus may also be seen. Clinical <strong>photosensitivity</strong> in the form of polymorphous light reaction and pruritus is associated with more severe systemic disease.</p>\n<p>The image given below shows a malar rash.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a9fd4549688a483d8e3c6f4542a8a9e6x512x395.PNG\" alt=\"Explanation Image\"><p>The FDA recently approved <strong>Canakinumab</strong> injection, an IL-1 inhibitor. It is first FDA-approved drug for the treatment of Still&rsquo;s disease, including Adult-Onset Still&rsquo;s Disease. The drug was previously approved for Systemic Juvenile Idiopathic Arthritis in patients aged two years and older.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5309",
      "difficulty": "medium"
    },
    {
      "text": "A 19-year-old woman presented to the hospital with complaints of progressive shortness of breath, chest pain, and lower extremity edema over the past month. Her initial laboratory values are given below. A renal biopsy showed the following. Which of the following antibodies is considered to be most specific for this disorder?<div class='question-desc-html'><ul>\n<li>Hemoglobin- 9.0 g/dL</li>\n<li>Platelet count- 116,000/&mu;L</li>\n<li>Serum creatinine- 2.68 mg/dL</li>\n<li>ANA titers- &gt;1:80.</li>\n<li>Urine protein- 3+</li>\n<li>Urine&nbsp;hemoglobin- 3+</li>\n</ul></div>",
      "choices": [
        {
          "id": 1,
          "text": "SS-A(Ro)"
        },
        {
          "id": 2,
          "text": "Anti-Sm"
        },
        {
          "id": 3,
          "text": "Anti ds-DNA"
        },
        {
          "id": 4,
          "text": "Antihistone"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical details and histopathology are suggestive of <strong>systemic lupus erythematosus</strong> (SLE).<strong> Anti‐Smith</strong> (anti‐Sm)<strong> antibodies</strong> are present in only approximately 30% of patients with SLE, but are considered highly&nbsp;<strong>specific</strong> for the disease and are included in the ACR criteria.</p>\n<p>Most <strong>sensitive</strong>&nbsp;antibody:&nbsp;<strong>ANA</strong></p>\n<p>In the image below, the glomerulus is hypercellular (endocapillary proliferation). Glomerular capillary loops appear circumferentially thickened, forming a&nbsp;\"wire loop\" lesion, which is&nbsp;classically seen in class IV or diffuse proliferative lupus nephritis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b7389cdbd5b64d4c905c256d19e1dfc1x1280x911.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Antibodies in Systemic lupus erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates  with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP <br />More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br />More common in blacks and whites </td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br />Primarily 60kDA and 52kDA</td>\n<td>Not Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased  risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br />(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp; β2 G1,<br />Sensitive prothrombin time (DRVVT)<br />Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane </td>\n<td> Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br />This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br />(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/04e984b28c0c46ba9ad231e2118bdec8.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5401",
      "difficulty": "medium"
    },
    {
      "text": "A 16-year-old boy who presented with joint pains and the following rash was diagnosed with SLE after a thorough work-up. Which of the following statements is incorrect regarding his diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-ds DNA correlates with disease activity"
        },
        {
          "id": 2,
          "text": "Anti-Sm correlates with disease activity"
        },
        {
          "id": 3,
          "text": "Anti-Ro antibody is associated with photosensitivity"
        },
        {
          "id": 4,
          "text": "Rim pattern of ANA positivity is specific for SLE"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Anti‐Smith</strong> (anti‐Sm)<strong> antibodies</strong> are present in approximately 30% of patients with SLE, but are considered highly&nbsp;<strong>specific</strong> for the disease and are included in the ACR criteria,&nbsp;however, they are <strong>not of use</strong> in <strong>monitoring</strong> overall lupus <strong>disease activity.&nbsp;</strong>Anti-ds DNA levels often correlate with disease activity.</p>\n<p>The image shows the characteristic malar rash.</p>\n<p><strong>Anti‐Ro</strong> antibody occurs in approximately 30&ndash;40% of patients, who have an increased tendency to <strong>photosensitivity, secondary Sj&ouml;gren</strong> syndrome, interstitial pneumonitis, shrinking lung syndrome, or deforming arthropathy, as well as being a marker for <strong>neonatal lupus.</strong></p>\n<p><strong>Rim pattern</strong> of <strong>ANA</strong> positivity is <strong>specific</strong> for SLE.</p><hr><h3>Related Pearl: Antibodies in Systemic lupus erythematosus (SLE)</h3><table>\n<tbody>\n<tr>\n<td><strong>Antibody</strong></td>\n<td><strong>Prevelance %</strong></td>\n<td><strong>Antigen Recognized</strong></td>\n<td><strong>Clinical utility</strong></td>\n</tr>\n<tr>\n<td>Antinuclear Antibody</td>\n<td>98</td>\n<td>Multiple nuclear</td>\n<td>Best screening test; repeated -ve test make SLE unlikely</td>\n</tr>\n<tr>\n<td>Anti dS-DNA</td>\n<td>70</td>\n<td>DNA(double stranded)</td>\n<td>High titres are SLE specific &amp; in some patients correlates  with disease activity, nephritis &amp; vasculitis</td>\n</tr>\n<tr>\n<td>Anti-Sm</td>\n<td>25</td>\n<td>Protein complexed to 6 species of nuclear U1 RNA</td>\n<td>Specific for SLE; no definite correlations; most patients also have anti RNP <br />More common in black &amp; asians than white</td>\n</tr>\n<tr>\n<td>Anti-RNP</td>\n<td>40</td>\n<td>Protein complexed to U1 RNA</td>\n<td>Not Specific for SLE; high titre associated with syndromes that have overlap features of several rheumatic syndromes including SLE;<br />More common in blacks and whites </td>\n</tr>\n<tr>\n<td>Anti-Ro( SS-A)</td>\n<td>30</td>\n<td>Protein complexed to hY RNA,<br />Primarily 60kDA and 52kDA</td>\n<td>Not Specific for SLE; associated with sicca syndrome, predisposes to subacute cutaneous lupus &amp; to neonatal lupus with congenital heart block; associated with decrease risk of nephritis</td>\n</tr>\n<tr>\n<td>Anti-La( SS-B)</td>\n<td>10</td>\n<td>47kDa protein complexed to hY RNA</td>\n<td>Usually associated with anti-RO, associated with decreased  risk for nephritis</td>\n</tr>\n<tr>\n<td>Antihistone</td>\n<td>70</td>\n<td>Histones associated with DNA<br />(In nucleosome &amp; chromatin)</td>\n<td>More frequent in drug induced lupus than in SLE</td>\n</tr>\n<tr>\n<td>Antiphospholipid</td>\n<td>50</td>\n<td>Phospholipid,β2 glycoprotein1(β2 G1) cofactor , prothrombin</td>\n<td>3 tests available-ELISAs for cardiolipin &amp; β2 G1,<br />Sensitive prothrombin time (DRVVT)<br />Predisposes to clotting, fetal loss, thrombocytopenia</td>\n</tr>\n<tr>\n<td>Antierythrocyte</td>\n<td>60</td>\n<td>Erythrocyte membrane </td>\n<td> Measured as direct Coombs test , a small proportion devlop overt hemolysis</td>\n</tr>\n<tr>\n<td>Antiplatelet</td>\n<td>30</td>\n<td>Surface &amp; altered cytoplasmic antigens on platelets</td>\n<td>Associated with thrombocytopenia, but sensitivity &amp; specificity are not good:<br />This is not a useful clinical test</td>\n</tr>\n<tr>\n<td>Antineuronal<br />(includes antiglutamate receptor)</td>\n<td>60</td>\n<td>Neuronal &amp; lymphocyte surface antigens</td>\n<td>In some series, a positive test in CSF correlates with active CNS lupus</td>\n</tr>\n<tr>\n<td>Antiribosomal P</td>\n<td>20</td>\n<td>Protein in ribosomes</td>\n<td>In some series, a positive test serum correlates with depression or psychosis due to CNS lupus</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/49ecfbc6aea640ebae853119b8899f97.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5402",
      "difficulty": "medium"
    },
    {
      "text": "An infant born to an asymptomatic mother was found to have typical cutaneous and serological findings of neonatal lupus syndrome. Anti-Ro and anti-La antibodies were detected in both the mother and the child. Which of the following statements is true regarding the child's condition?",
      "choices": [
        {
          "id": 1,
          "text": "Approximately 90% of the infants manifest cutaneous lesions"
        },
        {
          "id": 2,
          "text": "Rash resolves over few months with scarring"
        },
        {
          "id": 3,
          "text": "UV exposure has no effect on the rash"
        },
        {
          "id": 4,
          "text": "The most common finding is raccoon sign"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The <strong>most common</strong> fin<strong>ding</strong> in neonatal lupus erythematosus (<strong>NLE</strong>) is an<strong> erythematous, slightly scaly eruption</strong> on the <strong>face</strong> and<strong> periorbital skin</strong> (<strong>raccoon sign</strong>/owl eye/eye mask).</p>\n<p>NLE is a well‐recognized subtype of lupus erythematosus, thought to be caused by the <strong>transplacental </strong>passage of maternal <strong>antibodies.</strong></p>\n<p>The most frequent clinical manifestations are cutaneous lesions and<strong> congenital heart block</strong> (CHB).&nbsp;Approximately <strong>50%</strong> of infants manifest skin lesions, which may be <strong>present at birth</strong> or occur in the <strong>first few weeks of life</strong>. The eruption can be <strong>exacerbated</strong> by<strong> UV exposure.</strong></p>\n<p>The rash improves over the first few months of life and has usually resolved <strong>without scarring</strong> by 12 months of age. Skin disease is often mild and often<strong> requires no treatment</strong>.&nbsp;</p>\n<p>The image given below shows typical raccoon eyelid lesions&nbsp;in neonatal lupus erythematosus.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f738f4ca980a4852b2a1e1238609f2f3x1280x1138.2792665726374.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2776",
      "difficulty": "hard"
    },
    {
      "text": "A 33-year-old patient presented with myalgia, difﬁculty in climbing stairs, getting up from squatting position, and combing his hair for 3 months. An edematous purplish-red periorbital rash was seen. Investigations revealed elevated creatinine kinase levels. Muscle biopsy revealed perifascicular and perivascular lymphocytic infiltrates with muscle fiber degeneration. Which of the following is not true regarding this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Dysphagia points to a worse prognosis"
        },
        {
          "id": 2,
          "text": "Muscle tenderness is common"
        },
        {
          "id": 3,
          "text": "20 to 40% of patients have an underlying malignancy"
        },
        {
          "id": 4,
          "text": "Dilated capillary loops in nail fold can be seen"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above clinical scenario is suggestive of <strong>dermatomyositis. </strong>Muscle tenderness is not common in this disorder.</p>\n<p>It<strong>&nbsp;</strong>is an autoimmune disorder affecting, predominantly, the <strong>skin</strong> and <strong>skeletal muscle </strong>and&nbsp;usually presents<strong> initially</strong> with a <strong>facial rash </strong>especially around eyelids which can be pruritic and sore.&nbsp;<strong>Myositis</strong> symptoms are usually <strong>weakness</strong> and <strong>fatigue</strong> especially while climbing stairs, raising arms, and standing from sitting due to proximal muscle weakness.</p>\n<p>The presence of&nbsp;<strong>dysphagia</strong>&nbsp;points to a <strong>poorer</strong> <strong>prognosis</strong>.</p>\n<p>The <strong>clinical signs</strong> seen in dermatomyositis are as follows:</p>\n<ul>\n<li>Heliotrope rash around eyelids with a lilac hue.</li>\n<li><strong>Gottron papules -&nbsp;</strong>flat-topped lichenoid eruption on the proximal and distal interphalangeal joint</li>\n<li><strong>Shawl sign or V sign</strong>&nbsp;- fixed erythematous macular erythema)</li>\n<li><strong>Nail fold changes</strong> with<strong> periungal erythema </strong>with visible dilated capillary loops in the proximal nail fold</li>\n<li><strong>Proximal myopathy</strong></li>\n<li>Poikiloderma atrophicans vasculare</li>\n<li>Calcinosis cutis</li>\n</ul>\n<p>Approximately 20 to 40% of patients have an underlying malignancy (eg, lung, ovarian, breast) and hence screening should be done at the time of diagnosis.</p>\n<p>The image below shows ragged cuticle and periungueal erythema in a patient with dermatomyositis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/42d5abac25a84f59a8480e1f6d87ef7ax1280x1182.5105782792666.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5283",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following disorders is the following sign seen?",
      "choices": [
        {
          "id": 1,
          "text": "Discoid lupus erythematosus"
        },
        {
          "id": 2,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 3,
          "text": "Dermatomyositis"
        },
        {
          "id": 4,
          "text": "Localised scleroderma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The image shows a <strong>maculopapular rash</strong> on the <strong>lateral thigh</strong> which is also known as the<strong> holster sign</strong>, seen in <strong>dermatomyositis</strong>.</p>\n<p>The buttocks are often involved and confluent macular violaceous&nbsp;erythema over the hips and lateral thighs has been termed the &lsquo;holster sign&rsquo; corresponding to the site of hanging a holster.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/077f896ca371464e96edd079f47ad70dx1280x1664.5416078984485.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/97a26715c0014f97964b584e0f4ea47c.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5397",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following autoantibodies shows a strong association with the given clinical condition?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-Mi-2"
        },
        {
          "id": 2,
          "text": "Anti P155/P140"
        },
        {
          "id": 3,
          "text": "Anti Jo-1"
        },
        {
          "id": 4,
          "text": "Anti Scl-70"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The image shows&nbsp;<strong>pathognomonic </strong>involvement of eyelids in dermatomyositis in which the<strong> upper eyelids</strong> are<strong> preferentially affected </strong>with&nbsp;<strong>erythema</strong> that is lilac in color called<strong>&nbsp;heliotrope rash. </strong>This is associated with<strong> anti-Mi-2 antibodies.</strong></p>\n<p><strong>Gottron&rsquo;s papule</strong>, <strong>h</strong><strong>eliotrope rash</strong>, and <strong>s</strong><strong>hawl sign</strong>&nbsp;are associated with <strong>anti-Mi2 antibodies</strong>.</p>\n<p>Mechanic hand, Myositis, and ILD (Interstitial Lung Disease) are associated with anti‐histidyl tRNA synthetase (<strong>anti-Jo-1</strong>) antibodies.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/a7199b6d601146efb424d852abb0c474.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5311",
      "difficulty": "hard"
    },
    {
      "text": "Identify Gottron’s sign.",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Gottron's sign</strong> refers to <strong>erythematous or violaceous</strong>, <strong>macules</strong> or <strong>patches</strong> in the same symmetric distribution pattern but <strong>sparing </strong>the <strong>interphalangeal spaces</strong> and sometimes involving<strong> elbows</strong> and<strong> knees</strong>.</p>\n<p>This should not be confused with Gottron's papules.</p>\n<p><strong>Gottron’s papules </strong>are <strong>v</strong><strong>iolaceous </strong>(of violet color), <strong>l</strong><strong>ichenoid </strong>(red-purple), inflammatory, flat-topped <strong>papules</strong> on proximal interphalangeal joints, distal interphalangeal joints, and metacarpophalangeal joints. </p>\n<p> </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/369e034945a34e1ca6620d67520ffcd0x1280x1697.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/65a06a78b64742279d54537e340122fa.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5396",
      "difficulty": "hard"
    },
    {
      "text": "In which of the following conditions is this finding characteristically seen?",
      "choices": [
        {
          "id": 1,
          "text": "Discoid lupus erythematosus"
        },
        {
          "id": 2,
          "text": "Cutaneous scleroderma"
        },
        {
          "id": 3,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 4,
          "text": "Dermatomyositis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The image shows a&nbsp;<strong>confluent macular violaceous erythema </strong>called the <strong>V sign</strong>&nbsp;seen in patients of<strong>&nbsp;dermatomyositis.</strong></p>\n<p>It<strong>&nbsp;</strong>is an autoimmune disorder affecting, predominantly, the&nbsp;<strong>skin</strong>&nbsp;and&nbsp;<strong>skeletal muscle&nbsp;</strong>and&nbsp;usually presents<strong>&nbsp;initially</strong>&nbsp;with a&nbsp;<strong>facial rash,&nbsp;</strong>especially around eyelids, which can be pruritic and sore.&nbsp;<strong>Myositis</strong>&nbsp;symptoms are usually&nbsp;<strong>weakness</strong>&nbsp;and&nbsp;<strong>fatigue</strong>&nbsp;especially while climbing stairs, raising arms, and standing from sitting due to proximal muscle weakness.</p>\n<p>The presence of&nbsp;<strong>dysphagia</strong>&nbsp;points to a&nbsp;<strong>poorer</strong>&nbsp;<strong>prognosis</strong>.</p>\n<p>The&nbsp;<strong>clinical signs</strong>&nbsp;seen in dermatomyositis are as follows:</p>\n<ul>\n<li>Heliotrope rash around eyelids with a lilac hue.</li>\n<li><strong>Gottron papules -&nbsp;</strong>flat-topped lichenoid eruption on the proximal and distal interphalangeal joint</li>\n<li><strong>Shawl sign or V sign</strong>&nbsp;- fixed erythematous macular erythema</li>\n<li><strong>Nail fold changes</strong>&nbsp;with<strong>&nbsp;periungual&nbsp;erythema&nbsp;</strong>with visible dilated capillary loops in the proximal nail fold</li>\n<li><strong>Proximal myopathy</strong></li>\n<li>Poikiloderma atrophicans vasculare</li>\n<li>Calcinosis cutis</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/40c43dd8c3f04527907abf2dadb68bcb.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5395",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old female patient came with complaints of her hands turning very pale on exposure to cold for one month. She also gives a history of hand pain and swelling for the past 3 months. She informed that her skin felt firm and tight. Her past medical history is positive for GERD and arthritis. Image A shows a particular feature of this patient. On investigation, she was found to have the following immunofluorescence pattern (image B). Identify the wrong statement regarding her condition.",
      "choices": [
        {
          "id": 1,
          "text": "Interstitial lung disease is common in patients with Scl-70 antibodies"
        },
        {
          "id": 2,
          "text": "Telangiectasias and calcinosis are early manifestations"
        },
        {
          "id": 3,
          "text": "Earliest cutaneous manifestations are non‐pitting oedema and puffiness"
        },
        {
          "id": 4,
          "text": "Pruritus correlates with severity of cutaneous sclerosis"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario featuring Raynaud's phenomenon, arthritis, GERD, and calcinosis cutis is suggestive of <strong>systemic sclerosis</strong>. <strong>Mat-like telangiectases</strong> on the face and upper trunk and limbs, and <strong>cutaneous calcinosis</strong>, most often on the fingers over joints and at pressure points, develop in the<strong> later stages,&nbsp;</strong>particularly in the <strong>limited systemic</strong> form of systemic sclerosis, or <strong>CREST syndrome.</strong></p>\n<p>Image A is a classical fish mouth appearance (<strong>microstomia</strong>). Image B shows the&nbsp;<strong>nucleolar pattern</strong>&nbsp;of IF(some spots of fluorescence within the nucleus and it represents antibodies to RNA). This is seen in&nbsp;systemic sclerosis.</p>\n<p>The majority of cases are <strong>adult-onset&nbsp;</strong>with&nbsp;<strong>Raynaud's phenomenon</strong> as the<strong> first symptom</strong>.&nbsp;</p>\n<p>The earliest cutaneous manifestations are <strong>non‐pitting edema</strong> and<strong> puffiness</strong>, which tend to be seen first in the fingers, hands, and face.&nbsp;The skin becomes taut, indurated, thickened, and then fixed to deeper structures on the fingers resulting in <strong>sclerodactyly</strong>.</p>\n<p><strong>Pruritus</strong> is described in 40% of patients and may be intense during the early or active stages of the disease. It <strong>correlates</strong> with the extent of <strong>skin sclerosis</strong> and<strong> gastrointestinal symptoms</strong>.</p>\n<p><strong>Anti-scl-70</strong> positivity in this disease is useful in predicting those at higher risk for interstitial lung disease.&nbsp;<strong>Anti centromere</strong>&nbsp;antibody is most specific for&nbsp;<strong>CREST</strong>&nbsp;syndrome.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/2319d86d3dfb46d187355f07467c85e0.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5400",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is not a feature of the condition shown below?",
      "choices": [
        {
          "id": 1,
          "text": "Muscle weakness"
        },
        {
          "id": 2,
          "text": "Gastroesophageal reflux disease"
        },
        {
          "id": 3,
          "text": "Loss of sweat glands in distal extremities"
        },
        {
          "id": 4,
          "text": "Female preponderance of 9:1"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The image shows a young woman with <strong>mask-like facies</strong> with stretched, shiny skin, and loss of normal facial lines, <strong>microstomia,</strong> and <strong>pitted scarring</strong> on the right index <strong>finger</strong> which is suggestive of <strong>scleroderma</strong> or<strong> systemic sclerosis</strong>, an autoimmune rheumatic disease in which there is a <strong>4: 1 female predominance</strong>.</p>\n<p>Cutaneous features:</p>\n<ul>\n<li>Hands and feet - Raynaud's phenomenon, non-pitting edema, painful ulcerations which heal with<strong> pitted scars,</strong> sclerodactyly, contractures,<strong> loss of sweat glands</strong>, bone resorption.</li>\n<li>Face - periorbital edema, <strong>mask-like facies</strong>, telangiectasia, and <strong>diffuse hyperpigmentation</strong></li>\n<li>Trunk - firm, shiny, and thickened skin</li>\n</ul>\n<p>The&nbsp;<strong>extent of skin sclerosis</strong>&nbsp;in&nbsp;<strong>s</strong><strong>ystemic&nbsp;sclerosis</strong>&nbsp;can be measured, most commonly employing a&nbsp;<strong>modified Rodnan skin score</strong>&nbsp;(MRSS).</p>\n<p>Systemic features:</p>\n<ul>\n<li>GIT- dysphagia,<strong> GERD</strong>, diminished peristalsis, malabsorption</li>\n<li>Lungs- <strong>pulmonary fibrosis</strong> and alveolitis</li>\n<li>Heart- cardiac conduction defects, heart failure</li>\n<li>Kidney- uremia, malignant hypertension</li>\n<li>Musculoskeletal- weakness, <strong>carpal tunnel syndrome</strong></li>\n</ul>\n<p>The image below shows typical facial features: note the expressionless facies, mat‐like telangiectases, microstomia, perioral furrowing, and beak‐like nose.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/25a7fc636f6242d7b9556e59c971b1c6x720x1059.JPEG\" alt=\"Explanation Image\"><p>The image below shows digital ulceration</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/72bb07d925094354a4083b45c79558c0x576x384.PNG\" alt=\"Explanation Image\"><p>The image below shows advanced‐stage sclerodactyly with contractures and vasculopathic ulcers over the bony prominences</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/e58eaaa5f65d4cd19631189bab0fdea9x576x371.PNG\" alt=\"Explanation Image\"><p>In systemic sclerosis, progressive loss of fingerprints is seen in patients. These altered fingerprint ridges are seen due to&nbsp;changes in skin elasticity,&nbsp; hardness, and thickness&nbsp;and eventually make a patient with scleroderma a &ldquo;fingerprintless person&rdquo;.</p>\n<p>Autoantibody patterns seen in systemic sclerosis:</p>\n<ul>\n<li>Reactivity to autoantibodies such as anticentromere (ACA)&nbsp;is commonly seen in limited skin sclerosis.</li>\n<li>Reactivity to autoantibodies such as antitopoisomerase 1 antibody (<strong>anti‐Scl‐70 or ATA</strong>), and anti‐RNA polymerase III antibody (<strong>ARA or RNAP</strong>) is commonly seen in <strong>SSc</strong>.</li>\n</ul>\n<p>&nbsp;</p>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/8f83d459c8b44070b59f6a729b0d1b92.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA5307",
      "difficulty": "hard"
    },
    {
      "text": "The image shows an investigative modality of nail folds. This along with ANA testing helps in the early diagnosis of:",
      "choices": [
        {
          "id": 1,
          "text": "Dermatomyositis"
        },
        {
          "id": 2,
          "text": "Systemic sclerosis"
        },
        {
          "id": 3,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 4,
          "text": "Mixed connective tissue disorder"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows&nbsp;<strong>nail-fold capillaroscopy</strong> findings. The image shows giant capillaries, hemorrhages, and reducing capillary density suggesting an active pattern in&nbsp;<strong>systemic sclerosis</strong>.</p>\n<p>The most important tests for systemic sclerosis are <strong>ANA reactivity</strong> and<strong> nail fold capillaroscopy. </strong>Investigations to exclude or confirm other autoimmune rheumatic diseases including arthritis or other forms of connective tissue disease are also done.&nbsp;</p>\n<p>Nail-fold capillaroscopy is a <strong>non-invasive</strong>, easy, and safe diagnostic technique designed to evaluate the <strong>general architecture of capillary rows</strong> and <strong>fine details</strong> of small vessels of the microcirculation in the nail fold.</p>\n<p>The most important indications for performing capillaroscopy include differential diagnosis of <strong>primary</strong> and<strong> secondary Raynaud's phenomenon</strong>, as well as the&nbsp;assessment of scleroderma spectrum disorders.</p>\n<p>In systemic sclerosis, capillary abnormalities appear and evolve in a clearly defined sequence called the <strong>scleroderma pattern</strong>, which<strong> correlates with internal organ involvement</strong>.</p>\n<p>Nail fold capillaroscopy is also listed as a systemic sclerosis <strong>classification criterion</strong> recognized by the European League Against Rheumatism (<strong>EULAR</strong>).</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/aa382cf36199451299426c91a5057aff.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2784",
      "difficulty": "medium"
    },
    {
      "text": "A woman presented to the medicine OPD with complaints of dysphagia and her fingers turning white and then blue when exposed to cold. On examination, she has telangiectasias on the face and the given findings on her hands. Which of the following statements is correct regarding her condition?",
      "choices": [
        {
          "id": 1,
          "text": "Anti-centromere antibodies are most commonly found"
        },
        {
          "id": 2,
          "text": "Involvement of skin areas proximal to the knees or elbows"
        },
        {
          "id": 3,
          "text": "Rapid onset and progression of disease"
        },
        {
          "id": 4,
          "text": "Short history and less severe form of Raynaud's phenomenon"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The history along with the image showing <strong>calcinosis cutis</strong> and <strong>sclerodactyly</strong> are suggestive of <strong>CREST</strong> syndrome.</p>\n<p>In&nbsp;<strong>limited</strong>&nbsp;<strong>cutaneous systemic sclerosis</strong> or CREST syndrome,&nbsp;<strong>anti-centromere antibodies</strong> are the most commonly found antibodies.</p>\n<p>All other options are true for <strong>diffuse</strong>&nbsp;cutaneous systemic sclerosis, not CREST syndrome.</p><hr><h3>Related Pearl: Diffuse Cutaneous Systemic Sclerosis  Versus Limited Cutaneous Systemic Sclerosis</h3><table>\n<tbody>\n<tr>\n<td><strong>Characteristic feature</strong></td>\n<td><strong>Diffuse cutaneous systemic sclerosis</strong></td>\n<td><strong>Limited cutaneous systemic sclerosis</strong></td>\n</tr>\n<tr>\n<td>Skin involvement</td>\n<td>\n<p>Rapid progression</p>\n<p>Involvement of the skin areas <strong>proximal</strong> <strong>to the knees or elbows</strong> or over the anterior chest, trunk, or abdomen</p>\n</td>\n<td>\n<p>Slow progression</p>\n<p>Limited to face and skin <strong>distal</strong> <strong>to the elbows and knees</strong></p>\n<p> </p>\n<p> </p>\n</td>\n</tr>\n<tr>\n<td>Raynaud’s phenomenon</td>\n<td>\n<p>Less severe</p>\n<p> </p>\n<p><strong>Short history</strong> </p>\n</td>\n<td>\n<p>More severe; commonly associated with critical limb ischemia.</p>\n<p><strong>Long history</strong> </p>\n</td>\n</tr>\n<tr>\n<td>Musculoskeletal</td>\n<td><strong>Severe arthralgia</strong>, carpal tunnel syndrome, and tendon friction rubs</td>\n<td><strong>Mild</strong> arthralgia</td>\n</tr>\n<tr>\n<td>Pulmonary manifestation</td>\n<td>Interstitial lung disease more common</td>\n<td>Pulmonary artery hypertension (PAH) is equal in both</td>\n</tr>\n<tr>\n<td>Scleroderma renal crisis</td>\n<td>Occurs usually &lt;4 years of disease onset</td>\n<td>Very rare</td>\n</tr>\n<tr>\n<td>Calcinosis cutis</td>\n<td>Less common</td>\n<td>More common &amp; prominent</td>\n</tr>\n<tr>\n<td>Auto-antibodies</td>\n<td>\n<p><strong>Anti-topoisomerase I</strong> (Scl-70)</p>\n<p>anti-RNA polymerase III</p>\n</td>\n<td><strong>Anti centromere</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/35bb13425bb64e78b9164796e0c2fc29x1280x2412.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/27f5a3ed75ea4b3cb8fbd161589ef046.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2787",
      "difficulty": "medium"
    },
    {
      "text": "Identify the false statement regarding morphea.",
      "choices": [
        {
          "id": 1,
          "text": "Plaque morphea is the most common form"
        },
        {
          "id": 2,
          "text": "Absence of sclerodactyly and nail fold capillary changes"
        },
        {
          "id": 3,
          "text": "Antitopoisomerase and anticentromere are usually positive"
        },
        {
          "id": 4,
          "text": "Encoup de Sabre is linear morphea presenting as scarring alopecia"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>Autoantibodies such as <strong>ANA, anti-histone, and anti‐ssDNA</strong> may be present in <strong>morphea</strong>, but the systemic sclerosis specific autoantibodies such as anti-topoisomerase, anti-centromere and anti‐RNA polymerase are rarely found.</p>\n<p>Morphoea, a term used in preference to &lsquo;<strong>localized scleroderma</strong>&rsquo;, encompasses a group of related conditions characterized by varying degrees of <strong>sclerosis, fibrosis, and atrophy</strong> in the skin and subcutaneous tissues.</p>\n<p>It is distinguished from systemic sclerosis by the <strong>absence</strong> of sclerodactyly and nail-fold capillary changes.</p>\n<p>Overall, <strong>plaque morphea</strong>&nbsp;is the <strong>commonest subtype.</strong></p>\n<p>Morphoea en coup de sabre:<strong> Blaschkoid linear induration</strong> affecting the face and scalp, may involve underlying muscle, bone, eye, and the brain.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0ae9dfcfe69e41edac080c63fdef2026x1280x962.2566995768689.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a27b758543224fcb84e47e24b665a82cx1280x1129.2524682651622.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2786",
      "difficulty": "medium"
    },
    {
      "text": "A man presented with salt and pepper skin changes on his chest and back and with shortness of breath. A CT revealed fibrotic changes in the lower lobe of both the lungs. What is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Rheumatoid arthritis"
        },
        {
          "id": 2,
          "text": "Systemic lupus erythematosus"
        },
        {
          "id": 3,
          "text": "Dermatomyositis"
        },
        {
          "id": 4,
          "text": "Systemic sclerosis"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>Salt-and-pepper appearance is characterized by the presence of <strong>patchy hypopigmentation</strong> and<strong> hyperpigmentation</strong> of the skin manifesting as <strong>depigmentation</strong> with<strong> perifollicular pigmentary retention. </strong>This along with lung fibrosis is seen in <strong>systemic sclerosis.</strong></p>\n<p>This appearance may also be seen&nbsp;in areas of repigmentation in lesions of vitiligo.</p>\n<p>The image below shows salt and pepper appearance of skin over the abdomen seen in systemic sclerosis.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8691e2a4bd894688894107baf1891e92x357x535.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC2785",
      "difficulty": "medium"
    }
  ]
}